Vertex-partnered gene therapy startup raises $110M
Affinia Therapeutics, the gene therapy startup founded in 2019 based on research out of Massachusetts Eye and Ear and Harvard Medical School, has raised $110 million as it looks to file its first new drug application within the next year.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news
More News: Gene Therapy | Genetics | Harvard | Health Management | New Drug Applications | Pharmaceuticals